Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 01 05 2021
accepted: 09 09 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 18 12 2021
Statut: epublish

Résumé

Advanced donor age is a risk factor for poor survival following lung transplantation. However, recent work identifying epigenetic determinants of aging has shown that biologic age may not always reflect chronologic age and that stressors can accelerate biologic aging. We hypothesized that lung allografts that experienced primary graft dysfunction (PGD), characterized by poor oxygenation in the first three post-transplant days, would have increased biologic age. We cultured airway epithelial cells isolated by transbronchial brush at 1-year bronchoscopies from 13 subjects with severe PGD and 15 controls matched on age and transplant indication. We measured epigenetic age using the Horvath epigenetic clock. Linear models were used to determine the association of airway epigenetic age with chronologic ages and PGD status, adjusted for recipient PGD risk factors. Survival models assessed the association with chronic lung allograft dysfunction (CLAD) or death. Distributions of promoter methylation within pathways were compared between groups. DNA methyltransferase (DNMT) activity was quantified in airway epithelial cells under hypoxic or normoxic conditions. Airway epigenetic age appeared younger but was strongly associated with the age of the allograft (slope 0.38 per year, 95% CI 0.27-0.48). There was no correlation between epigenetic age and recipient age (P = 0.96). Epigenetic age was 6.5 years greater (95% CI 1.7-11.2) in subjects who had experienced PGD, and this effect remained significant after adjusting for donor and recipient characteristics (P = 0.03). Epigenetic age was not associated with CLAD-free survival risk (P = 0.11). Analysis of differential methylation of promoters of key biologic pathways revealed hypomethylation in regions related to hypoxia, inflammation, and metabolism-associated pathways. Accordingly, airway epithelial cells cultured in hypoxic conditions showed suppressed DNMT activity. While airway methylation age was primarily determined by donor chronologic age, early injury in the form of PGD was associated with increased allograft epigenetic age. These data show how PGD might suppress key promoter methylation resulting in long-term impacts on the allograft.

Identifiants

pubmed: 34691018
doi: 10.3389/fimmu.2021.704172
pmc: PMC8528961
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

704172

Subventions

Organisme : CSRD VA
ID : I01 CX002011
Pays : United States
Organisme : BLRD VA
ID : IK2 BX005301
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136962
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151552
Pays : United States

Informations de copyright

Copyright © 2021 Dugger, Calabrese, Gao, Deiter, Tsao, Maheshwari, Hays, Leard, Kleinhenz, Shah, Golden, Kukreja, Gordon, Singer and Greenland.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Transplant. 2021 Jun;21(6):2145-2160
pubmed: 33078555
Genome Biol. 2013;14(9):R102
pubmed: 24034465
Nature. 2016 Sep 1;537(7618):63-68
pubmed: 27533040
Nat Rev Mol Cell Biol. 2020 Mar;21(3):137-150
pubmed: 32020082
Curr Opin Physiol. 2019 Feb;7:21-26
pubmed: 31403087
PM R. 2011 Sep;3(9):868-72
pubmed: 21944304
Ann Thorac Surg. 2010 May;89(5):1555-62
pubmed: 20417777
Nat Commun. 2018 Jan 26;9(1):387
pubmed: 29374233
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Hum Mol Genet. 2014 Apr 15;23(8):2176-88
pubmed: 24301681
Am J Respir Crit Care Med. 2018 Jan 15;197(2):235-243
pubmed: 28872353
Am J Respir Cell Mol Biol. 2021 Mar;64(3):308-317
pubmed: 33196316
Transplant Proc. 2006 Dec;38(10):3344-6
pubmed: 17175268
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Genome Biol. 2019 Mar 14;20(1):55
pubmed: 30871603
J Thorac Dis. 2017 Oct;9(10):4084-4097
pubmed: 29268419
Thorax. 2017 Nov;72(11):1052-1054
pubmed: 28446663
Cell Rep Med. 2020 Jul 21;1(4):
pubmed: 32754722
Am J Transplant. 2013 Oct;13(10):2685-95
pubmed: 24034167
PLoS Genet. 2012;8(12):e1003146
pubmed: 23284304
Am J Transplant. 2016 Apr;16(4):1070-8
pubmed: 26780242
Exp Gerontol. 2018 Sep;110:230-240
pubmed: 29935294
Am J Respir Cell Mol Biol. 2020 Oct;63(4):490-501
pubmed: 32551854
Am J Transplant. 2021 Jan;21(1):362-371
pubmed: 32885581
J Heart Lung Transplant. 2019 May;38(5):493-503
pubmed: 30962148
Science. 2009 May 15;324(5929):930-5
pubmed: 19372391
Aging (Albany NY). 2017 Feb 14;9(2):419-446
pubmed: 28198702
Clin Transplant. 2018 Aug;32(8):e13332
pubmed: 29920787
Biochem Biophys Res Commun. 2012 Jun 15;422(4):697-702
pubmed: 22627137
Transplantation. 2008 Dec 27;86(12):1818-23
pubmed: 19104428
Transplant Direct. 2020 Jul 15;6(8):e576
pubmed: 33134500
Genes Dev. 2014 Apr 15;28(8):812-28
pubmed: 24736841
Aging Cell. 2019 Apr;18(2):e12897
pubmed: 30712319
J Heart Lung Transplant. 2013 Aug;32(8):760-8
pubmed: 23664760
Mol Cell. 2018 Sep 20;71(6):882-895
pubmed: 30241605
JCI Insight. 2016 Sep 8;1(14):e87871
pubmed: 27699235
Clin Epigenetics. 2018 May 22;10:67
pubmed: 29796118

Auteurs

Daniel T Dugger (DT)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Daniel R Calabrese (DR)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Medical Service, Veterans Affairs Health Care System, San Francisco, CA, United States.

Ying Gao (Y)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Fred Deiter (F)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Tasha Tsao (T)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Julia Maheshwari (J)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Steven R Hays (SR)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Lorriana Leard (L)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Mary Ellen Kleinhenz (ME)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Rupal Shah (R)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Jeff Golden (J)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Jasleen Kukreja (J)

Department of Surgery, University of California at San Francisco, San Francisco, CA, United States.

Erin D Gordon (ED)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Jonathan P Singer (JP)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

John R Greenland (JR)

Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Medical Service, Veterans Affairs Health Care System, San Francisco, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH